Treatment of parkinsonism with L-DOPA in association with a decarboxylase inhibitor-Reference-Cited by-同舟云学术

Treatment of parkinsonism with L-DOPA in association with a decarboxylase inhibitor

Published:1969-11 Issue:1 Volume:2 Page:23-26
ISSN:0031-6970
Container-title:Pharmacologia Clinica
language:en
Short-container-title:Pharmacol. Clin.

Author:

Siegfried J.,Ziegler W. H.,Regli F.,Fischer C.,Kaufmann W.,Perret E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00404181.pdf

Reference23 articles.

1. Barreau, A., G.F. Murphy, and T.L. Sourkes: Excretion of Dopamine in Diseases of Basal Ganglia. Science 133, 1706?1707 (1961).

2. , T.L. Sourkes et G.F. Murphy: Les catécholamines dans la maladie de Parkinson. In: Monoammes et Système Nerveux Central. Symposium Bel-Air, Genève, 1961, J. de Ajuriaguerra, Ed., 247?262. Genève: Georg 162.

3. Bartholini, G., H. M. Bates, W.P. Burkard, and A. Pletscher: Increase of Cerebral Catecholamines Caused by 3,4-Dihydroxy-phenylalanine after Inhibition of Peripheral Decarboxylase. Nature 215, 852?853 (1967).

4. Birkmayer, W.: Die Bedeutung des Monoamin-metabolismus für die Pathologie des extrapyramidalen Systems. Ars Medici 57, 814?831 (1967).

5. , u. O. Hornykiewicz: Der L-3,4Dioxyphenylalanin (= DOPA)-Effekt bei der Parkinson-Akinesie. Wien. klin. Wschr. 73, 787?788 (1961).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skin-contact Wearable Electrochemical Biosensing Tools: a perspective for the Well-being of Neurological Patients;TrAC Trends in Analytical Chemistry;2024-09

2. To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson’s disease;npj Parkinson's Disease;2023-06-24

3. Levodopa-induced dyskinesia: a historical review of Parkinson’s disease, dopamine, and modern advancements in research and treatment;Journal of Neurology;2022-01-17

4. PLASMA O-METHYLDOPA IN LEVODOPA-INDUCED DYSKINESIAS A Bioclinical Investigation;Acta Neurologica Scandinavica;2009-01-29

5. Catecholamine metabolism (and the biochemical assessment of sympathetic activity);Clinics in Endocrinology and Metabolism;1977-11